The Office of Clinical Pharmacology (OCP) at the U.S. Food and Drug Administration (FDA) is currently seeking policy fellows for a one-year fellowship to conduct OCP and FDA policy evaluations that will advance new drug development and promote therapeutic individualization. Potential project topics are diverse and will be instrumental in the development of both scientific and regulatory guidelines and policies.
A study on Alzheimer's disease to be conducted in Puerto Rico is recruiting volunteers. The Amaranth study will test a drug that attacks Alzheimer's disease in its early phase by avoiding the formation of the amyloid plaques that deposit in the brain and cause neuron damage.
WASHINGTON - The Federal Drug Administration (FDA) does not consider the use of transgenic mosquitoes to control the spread of Zika virus to have any adverse effects on the environment or the population, according to a preliminary study published today.
For the full article, please refer to the spanish version of this site.